Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 191Anemia, Refractory, with Excess of Blasts 179Myelodysplastic Syndromes 175Leukemia 168Precursor Cell Lymphoblastic Leukemia-Lymphoma 132Neoplasms 121Multiple Myeloma 116Venous Thromboembolism 111Anemia 108Leukemia, Myelomonocytic, Chronic 103Leukemia, Lymphocytic, Chronic, B-Cell 100Myeloproliferative Disorders 99Lymphoma, Non-Hodgkin 97Lymphoma 96Hodgkin Disease 85Thrombocytopenia 84Anemia, Aplastic 79Primary Myelofibrosis 67Lymphoma, Follicular 67Hematologic Neoplasms 63Leukemia, Myeloid, Chronic-Phase 61Lymphoma, Mantle-Cell 59Febrile Neutropenia 59Congenital Abnormalities 59Neoplasms, Plasma Cell 57Leukemia, Myeloid, Accelerated Phase 57Anemia, Refractory 57Leukemia, Myelogenous, Chronic, BCR-ABL Positive 56Blast Crisis 56Burkitt Lymphoma 53

Interventions

Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphangioma × Classical hematology × Clear all
NCT00975819 2026-01-06

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies

Boston Children's Hospital

Phase 2 Completed
61 enrolled 7 charts
Classical hematology

Tufted angioma, Lymphangioma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡